Download the full outcome
Detail of outcome
The government has published its response to the consultation on proposed changes to the statutory scheme that controls the cost of branded health service medicines.
A revised payment percentage for 2020 will be set from 1 April 2020 and the payment percentage for 2021 has been adjusted. These are set out in the response document.
There have been changes to the impact assessment in response to consultation feedback.
The finalised regulations and explanatory memorandum have been published.
This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded medicines.
The consultation focuses specifically on proposed amendments to the payment percentages that are currently set out in the legislation for the statutory scheme.
We propose adjusting the payment percentages for 2020 and 2021 to help ensure allowed growth in statutory scheme sales of branded medicines to the NHS is limited to the current rate of 1.1% per year.